Qforma Announces Alliance with Veeva Systems

Qforma Announces Alliance with Veeva Systems

Qforma's HCP Network Intelligence Platform to be integrated with both Veeva Network and Veeva CRM

Qforma's Network Intelligence platform captures the power of influence in local network HCP communities, enabling commercial teams to benefit from social and transactional big data to predict customer behavior.

For medical teams, Qforma Network Intelligence platform provides scalable information about national and local key opinion leaders (KOL). Qforma's KOL solution was recently awarded EuroPriSe certification for compliance with European regulations on data privacy and data security.

"Putting the power of influence and network analytics into the hands of the decision makers and the people closest to the customer is the goal of this alliance with Veeva," said Kilian Weiss, CEO of Qforma.  "Qforma is proud to be working with Veeva to integrate our product platforms.  We have a shared commitment to improving our clients' medical, marketing and sales endeavors."

About Qforma

Qforma, a BelHealth portfolio company, is a leading provider of social analytics for the life sciences industry. It is uniquely able to provide local, regional and global network intelligence comprised of transactional healthcare data and social and public domain data. Based on these data and proprietary analytic algorithms, Qforma helps its clients to understand, monitor and predict behavior in all relevant communities. Qforma applies its intelligence hub platform to optimize promotional campaigns, manage key influencers and execute product launches. Our enterprise solutions have helped clients around the world to increase company value. Qforma has a global presence with offices in Germany and Ukraine; along with two US based offices one in New Mexico and headquarters in Morris Plains, New Jersey.

For further information, please visit:
Qforma: www.qforma.com

Contact
Qforma: Kilian Weiss (973) 889-1300

About BelHealth Investment Partners

BelHealth Investment Partners, based in New York, is a healthcare private equity firm focused on lower middle market companies. BelHealth acquires majority positions in entrepreneur-owned companies we believe would benefit from our vast operating and private equity experience. The firm typically invests $10- 25 million per platform company across four healthcare segments: Services, Products, Distribution and Information Technology. Applying an active, hands-on approach, BelHealth utilizes its experience to support management to drive revenue, profit growth and achieve superior returns for our investors and partners.

For further information, please visit:
BelHealth Investment Partners: www.belhealth.com

Contact
BelHealth Investment Partners: Inder Tallur (347) 308-7018

Logo - http://photos.prnewswire.com/prnh/20140521/89896

SOURCE Qforma

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.